Get the Stockscreener App
19.48
1.04%
0.20
After Hours:
19.46
-0.02
-0.10%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $19.48, with a volume of 20.91M.
It is up +1.04% in the last 24 hours and up +1.83% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$19.28
Open:
$19.36
24h Volume:
20.91M
Relative Volume:
1.07
Market Cap:
$37.40B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
23.10
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
+2.42%
1M Performance:
+1.83%
6M Performance:
+11.31%
1Y Performance:
-14.71%
1-Day Range:
$19.28
$19.57
1-Week Range:
$18.77
$19.57
52-Week Range:
$14.02
$22.74
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, CCL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.48 | 37.02B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
148.63 | 343.26B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
61.37 | 131.22B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
91.98 | 72.62B | 20.80B | 2.22B | 3.77B | 2.5772 |
CCL
Colgate Palmolive Co
|
27.12 | 36.06B | 26.98B | 3.10B | 2.98B | 2.2492 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue Inc. stock rises Monday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Balance Sheet - TradingKey
Renaissance Technologies LLC Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Morningstar Investment Management LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC - MarketBeat
Kenvue, Inc. Revenue Breakdown – DUS:J4D - TradingView
Healthcare of Ontario Pension Plan Trust Fund Has $62.17 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady after latest earnings and outlook - AD HOC NEWS
Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE) - Yahoo Finance
Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight - Yahoo Finance UK
Naproxen-Powered Pain Relief Medications: Kenvue Receives FDA Approval for TYLENOL… - Trend Hunter
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse - Yahoo Finance
5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC - MarketBeat
GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE - MarketBeat
Bank of Nova Scotia Acquires 816,428 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue, Inc. Revenue Breakdown – FWB:J4D - TradingView
Kenvue, Inc. (KVUE) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
US FDA approves over-the-counter Tylenol combination pill for pain relief - Reuters
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kenvue Inc (KVUE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kenvue Says FDA Has Granted Tylenol Three-Year Exclusivity For New OTC Formulation - TradingView
FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) - Kenvue
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)? - simplywall.st
Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It - The Motley Fool
Kenvue Inc (KVUE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KVUE|Kenvue Inc|Price:19.477|Chg%:+0.197 - TradingKey
Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint by Kenvuemouthwash classic boosts oral care sales - Ad-hoc-news.de
Capula Management Ltd Grows Position in Kenvue Inc. $KVUE - MarketBeat
Caxton Associates LLP Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Thursday, still outperforms market - MarketWatch
Kenvue to announce Q2 2026 results on August 6, 2026 - scanx.trade
Press Release: Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - 富途牛牛
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue Inc (KVUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kenvue broadens China focus on minor ailment management - China Daily
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE - MarketBeat
The Listerine Cool Mint MouthwashKenvue bets on bold flavor and plaque control - Ad-hoc-news.de
Kenvue stock steadies as consumer health margins lift earnings outlook - Ad-hoc-news.de
Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating - marketscreener.com
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):